Company: IMRX
Filing Date: 2025-03-20
Form Type: 10-K
Source: 0001790340-25-000042
Chunk: 74

Company: Immuneering Corp
Filing Date: 2025-03-20
Form: 10-K
Item: Item 15
Chunk 74
---
Item 15. Exhibits and Financial Statement Schedules

(a) 1. Financial Statements

For a list of the financial statements included herein, see Index to Consolidated Financial Statements in this Annual Report on Form 10-K, incorporated into this Item by reference.

2.Financial Statement Schedules

Financial statement schedules have been omitted because they are either not required or not applicable or the information is included in the consolidated financial statements or the notes thereto.

3.Exhibits

See the Exhibit Index in Item 15(b) below.

142

Table of Contents

(b) EXHIBIT INDEX

Incorporated by ReferenceFiled/FurnishedHerewithExhibit NumberExhibit DescriptionFormFile No.ExhibitFilingDate2.1Share Purchase Agreement by and among Immuneering Corporation, BioArkive, Inc. and BioArkive’s shareholders, dated as of December 22, 20218-K001-406752.112/22/20213.1Amended and Restated Certificate of Incorporation of Immuneering Corporation10-Q001-406753.109/09/20213.2Amended and Restated Bylaws of Immuneering Corporation8-K001-406753.102/02/20244.1Form of Specimen Stock CertificateS-1/A333-2577914.107/26/20214.2Amended and Restated Investors’ Rights Agreement, dated December 21, 2020, by and among the Registrant and the other parties thereto.S-1/A333-2577914.207/26/20214.3Description of Securities10-K001-406754.33/10/202210.1†Employment Agreement, dated July 23, 2021, by and between Brett Hall, Ph.D. and Immuneering CorporationS-1/A333-25779110.607/26/202110.2†Employment Agreement, dated July 23, 2021, by and between Scott Barrett, M.D. and Immuneering CorporationS-1/A333-25779110.707/26/202110.3†Employment Agreement, dated July 23, 2021, by and between Benjamin J. Zeskind, Ph.D. and Immuneering CorporationS-1/A333-25779110.807/26/202110.4†Employment Agreement, dated July 23, 2021, by and between Mallory Morales and Imm